A premium documentary-drama series developed from Steven A. Hunt's SIC and the Phenomenal Longevity Alliance.
Positioned for premium streaming-buyer consideration — including Netflix — through qualified industry representation. This is an independent development project and is not affiliated with, endorsed by, or submitted directly to Netflix.
"A story about a broken system, a door out of it, and the people trying to build that door before another generation loses healthy years."
The Longevity House investigates the forces shortening American healthspan — chronic disease, ultra-processed food, outdated incentives, environmental exposure, and a sick-care economy built to manage decline rather than prevent it.
From there, the series turns toward the remedy: education, real-world behavior change, physician-led care, genomics, regenerative medicine, bioelectric research, and the secure participant infrastructure needed to support it responsibly.
Built for a premium streaming audience, the series is cinematic, emotional, and scientifically grounded — holding the tension between hope and proof, innovation and regulation, personal transformation and medical ethics.
A network of clinicians, founders, researchers, and technology builders operating within clearly stated boundaries. The Alliance does not diagnose, treat, cure, reverse aging, prevent disease, or guarantee outcomes.
Instead, it provides:
A 7-part limited documentary-drama series, supported by a companion social series and a 12-scene visual storyboard used for pitch and marketing materials.
Opens on hospitals, insurers, and pharma revenue lines — then reframes them against healthspan data. Interviews with physicians, patients, and health-economics researchers ground the crisis in numbers and lived experience.

A 90-day plan to lock the series bible, produce a sizzle reel, secure development capital, and bring the project to premium buyers through qualified industry representation.
Detailed financials, comparable acquisitions, and investment tiers are available in the private investor overview.
Full financial estimates — season cost, pre-money valuation, comparable acquisitions, and proposed investment tiers — are held in a private overview for qualified investors, producers, and entertainment representatives.
Access-controlled document. Enter the code you received to view series economics, the 90-day roadmap, success metrics, and next steps by audience.
The Longevity House is a documentary-drama series concept created for educational and entertainment purposes. The Phenomenal Longevity Alliance does not diagnose, treat, cure, reverse aging, prevent disease, or guarantee medical outcomes. Any medical, scientific, or wellness-related content featured in the series is subject to independent scientific review, participant consent, and ethical oversight. Viewers and prospective participants should consult a qualified healthcare professional for personal medical advice.
Internal reports prepared for the Board of Directors. Confidential — for review by qualified partners only.
All investor and sponsor names are prospect targets only. No discussions, letters of intent, or commitments exist with any listed party. Full reports are held internally and shared with qualified partners on request.
Public contact channels only. Route formal outreach through qualified representation.
$1B+ global healthspan R&D funder
Sergey Young · early-stage longevity
Michael Greve · rejuvenation biotech
Radical life-extension thesis
XPRIZE co-founder LP community
Private offices funding XPRIZE Healthspan
Johnson · Robbins · Sinclair · Mellon
Begin outreach with sizzle reel + integration menu (Month 01).
Consumer longevity diagnostics
Continuous glucose monitoring
Supplements + testing (Nasdaq: THRN)
Foundational nutrition category leader
Smart ring · sleep & biomarkers
Sleep-tech · Pod smart mattress
Full-body imaging & preventive scans
Qualified investors, producers, entertainment representatives, and strategic partners may request the private investor overview. Others may apply to follow the project's progress.